| # | Fund | Position value | Shares | Last move | As of | History |
|---|---|---|---|---|---|---|
| 1 | MPM BioImpact LLC | $86.5M | 4.8M | ▲New +4.8M sh | Q1 2026 | |
| 2 | EcoR1 Capital, LLC | $86.3M | 4.8M | ▲New +4.8M sh | Q1 2026 | |
| 3 | T. Rowe Price Investment Management, Inc. | Withheld | 2.1M | ▲New +2.1M sh | Q1 2026 | |
| 4 | BlackRock, Inc. | $37.8M | 2.1M | ▲New +2.1M sh | Q1 2026 | |
| 5 | RTW INVESTMENTS, LP | $28.5M | 1.6M | ▲New +1.6M sh | Q1 2026 | |
| 6 | PRICE T ROWE ASSOCIATES INC /MD/ | $28.0M | 1.6M | ▲New +1.6M sh | Q1 2026 | |
| 7 | RA CAPITAL MANAGEMENT, L.P. | $26.9M | 1.5M | ▲New +1.5M sh | Q1 2026 | |
| 8 | JANUS HENDERSON GROUP PLC | $26.0M | 1.5M | ▲New +1.5M sh | Q1 2026 | |
| 9 | BAKER BROS. ADVISORS LP | $17.8M | 996K | ▲New +996K sh | Q1 2026 | |
| 10 | Octagon Capital Advisors LP | $17.2M | 961K | ▲New +961K sh | Q1 2026 | |
| 11 | VANGUARD CAPITAL MANAGEMENT LLC | $14.9M | 834K | ▲New +834K sh | Q1 2026 | |
| 12 | EVENTIDE ASSET MANAGEMENT, LLC | $9.1M | 507K | ▲New +507K sh | Q1 2026 | |
| 13 | GEODE CAPITAL MANAGEMENT, LLC | $8.8M | 492K | ▲New +492K sh | Q1 2026 | |
| 14 | Avidity Partners Management LP | $8.4M | 469K | ▲New +469K sh | Q1 2026 | |
| 15 | STATE STREET CORP | $7.7M | 428K | ▲New +428K sh | Q1 2026 | |
| 16 | FMR LLC | $6.9M | 386K | ▲New +386K sh | Q1 2026 | |
| 17 | UBS Group AG | $6.3M | 353K | ▲New +353K sh | Q1 2026 | |
| 18 | ArrowMark Colorado Holdings LLC | $5.9M | 329K | ▲New +329K sh | Q1 2026 | |
| 19 | Alyeska Investment Group, L.P. | $5.2M | 290K | ▲New +290K sh | Q1 2026 | |
| 20 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $2.9M | 162K | ▲New +162K sh | Q1 2026 | |
| 21 | NORTHERN TRUST CORP | $2.7M | 149K | ▲New +149K sh | Q1 2026 | |
| 22 | VANGUARD FIDUCIARY TRUST CO | $2.3M | 127K | ▲New +127K sh | Q1 2026 | |
| 23 | VANGUARD PORTFOLIO MANAGEMENT LLC | $2.2M | 120K | ▲New +120K sh | Q1 2026 | |
| 24 | AMERIPRISE FINANCIAL INC | $1.8M | 103K | ▲New +103K sh | Q1 2026 | |
| 25 | TD ASSET MANAGEMENT INC | $1.8M | 101K | ▲New +101K sh | Q1 2026 |
Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.
| Company | Co-held by | Combined value |
|---|---|---|
| NVIDIA CORPNVDA | 17 funds | $12.2B |
| MICROSOFT CORPMSFT | 16 funds | $6.4B |
| MEDLINE INC-CL AMDLN | 16 funds | $541.3M |
| DISC MEDICINE INCIRON | 15 funds | $287.6M |
| BROADCOM INCAVGO | 14 funds | $3.5B |
| MICRON TECHNOLOGY INCMU | 14 funds | $3.0B |
| ADVANCED MICRO DEVICESAMD | 14 funds | $1.1B |
| ELECTRONIC ARTS INCEA | 14 funds | $1.1B |
| PRAXIS PRECISION MEDICINES IPRAX | 14 funds | $870.0M |
| EQUINIX INCEQIX | 14 funds | $867.4M |
| VAXCYTE INCPCVX | 14 funds | $804.6M |
| ENTERGY CORPETR | 14 funds | $544.1M |
Ranked by how many of AKTS's institutional holders also hold each name, a cross-fund conviction signal.
| Date | Insider | Role | Action | Shares | Value |
|---|---|---|---|---|---|
| Jul 8, 2026 | Czibere Akos | Chief Medical Officer | Sell (S) | 4K | $125K |
| Jul 8, 2026 | Czibere Akos | Chief Medical Officer | Sell (S) | 31K | $862K |
| Jul 8, 2026 | Czibere Akos | Chief Medical Officer | Sell (S) | 15K | $401K |
| Jul 8, 2026 | Ron-Bigger Shulamit | Chief Operating Officer | Sell (S) | 4K | $121K |
| Jul 8, 2026 | Ron-Bigger Shulamit | Chief Operating Officer | Sell (S) | 30K | $838K |
| Jul 8, 2026 | Ron-Bigger Shulamit | Chief Operating Officer | Sell (S) | 16K | $429K |
| Jan 12, 2026 | NODELMAN OLEG | Director | Buy (P) | 2.1M | $37.4M |
| Jan 12, 2026 | NODELMAN OLEG | Director | Buy (P) | 144K | $2.6M |
| Jan 12, 2026 | Kim Helen Susan | Director, 10% Owner | Buy (P) | 23K | $406K |
| Jan 12, 2026 | Kim Helen Susan | Director, 10% Owner | Buy (P) | 812K | $14.6M |
| Jan 12, 2026 | VIDA VENTURES II-A, LLC | 10% Owner | Buy (P) | 23K | $406K |
| Jan 12, 2026 | VIDA VENTURES II-A, LLC | 10% Owner | Buy (P) | 812K | $14.6M |
This stock page is the public Follow view. For one current, evidence-backed answer, use capital_change_brief through REST or MCP. It compares tracked 13F changes with qualifying Form 4 activity and cites the SEC evidence.
curl -H "Authorization: Bearer YOUR_API_KEY" \ "https://arkolith.com/api/v1/stocks/AKTS/capital-change-brief"
Use Arkolith's capital_change_brief for AKTS. Tell me what changed, whether insider activity corroborates it, and cite the SEC evidence.
13F holdings + Form 4 insider transactions + end-of-day price history + the live filing stream, joined for AKTS. Filings are public domain, sourced to SEC EDGAR; price series derived from end-of-day closes.